Welcome to Dendrite
Dendrite is a leading specialist provider of clinical database systems and registries. Clinical societies, research organisations, hospitals, government departments of health, medical device and pharmaceutical companies around the world are using our system for clinical research, audit, benchmarking and structured reporting. Our experience is unparalleled – over the years, we have implemented over 200 major national and international registries across various specialties, and hundreds of hospitals in 40+ countries are using our system for local research and service improvement.
Our system includes some unique and important features such as:

-
Design flexibility – the system is easily customised for each project and can be quickly updated
-
Flexible data analysis allowing users to build various types of graphs/tables with their data (e.g. funnel plots, VLAD plots, actuarial curves etc.)
-
Patient Reported Outcome Measures (ePROMs) function which collects data directly from patients via email/SMS messages - a game-changer for many projects in the last couple of years
-
Data security and GDPR compliance
-
Integration with EPR/HIS systems
Get in touch
We would be delighted to demonstrate our system and discuss your potential project.
Please complete the form below and a member of our team will contact you shortly.
Dendrite Clinical Systems is delighted to report that our Managing Director, Dr Peter Walton, has published a chapter discussing the value of clinical registries in new publication on Laparoscopic Sleeve Gastrectomy (LSG). In his Chapter, Dr Peter Walton outlines value of national bariatric registries and their capability to deliver evidence on a global basis, as well as providing some practical perspectives on best practice when setting out to start a national registry and how to keep a good registry going.
Dendrite Clinical Systems and the Institute for Health Research (IGES) in Berlin, Germany, have initiated the Outpatient Treatment of COVID-19 Infections (ABC-19) study, to record data on the treatment of COVID-19 patients and discover more about the outpatient course of the disease, the individual risk factors of patients that contribute to severe COVID-19 courses and the procedures of general practitioners (GPs).
Researchers at the University College London and University College London Hospitals NHS Foundation Trust), London, UK, have reported that the vast majority of participants with new onset loss of smell were positive for COVID19, and this acute loss of sense of smell needs to be considered globally as a criterion for self-isolation, testing and contact tracing in order to contain the spread of COVID-19.
Dendrite Clinical Systems’ innovative “Intellect Web” software has been chosen by an international group of 17 leading diabetes experts from the multidisciplinary Diabetes Surgery Summit (DSS), as the platform on which the CoviDiab project will establish a Global Registry to collect new cases of diabetes in patients with COVID-19.





